Caribou Biosciences, Inc.: 1 tracked 2026 layoff event(s), 87 workers counted, highest AI score 3.
AI score 3 (80% interval 2–4) · evidence grade D · CA · Pharma / Chemicals
Stated reason: On October 2, 2026, the Board of Directors (the “Board”) of Caribou Biosciences, Inc. (the “Company”) approved a restructuring of the Company’s operations (the “Restructuring”) as the Company conducts a process to explore strategic alternatives to maximize stockholder value, including the planned discontinuation of clinical trials and further development activities for the Company’s allogeneic CAR-T cell therapy prog…
Why 3: Plant, store or site closure · Drivers: contrary evidence −0.8, industry AI exposure +0.5, role AI exposure +0.1
Signals: attribution 0.0, primary 0.0, exec 0.0, role exposure 0.608, industry exposure 0.712, AI investment 0.0, contrary 0.55 · named roles: Computer and Information Systems Managers, General and Operations Managers, Nursing Assistants, Registered Nurses
Headcount basis: WARN (sum of state notices; company-wide total not disclosed) · WARN: 87 workers at 1 site notice(s)
Company AI financials (AI spending, revenue, earnings-call AI mentions) are coming soon to this page.
